Revolution Medicines Reports Board and Executive Changes
Ticker: RVMDW · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1628171
| Field | Detail |
|---|---|
| Company | Revolution Medicines, Inc. (RVMDW) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Rev Med shakes up board & exec comp. Big changes coming?
AI Summary
Revolution Medicines, Inc. announced on June 18, 2025, changes related to its board of directors and executive compensation. Specifically, the company reported the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for its officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation structures can introduce uncertainty and potential shifts in strategic direction.
Key Players & Entities
- Revolution Medicines, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 700 Saginaw Drive Redwood City, California 94063 (address) — Principal Executive Offices
- (650) 481-6801 (phone_number) — Registrant's telephone number
FAQ
Who departed from their officer roles at Revolution Medicines?
The filing indicates the departure of certain officers, but does not name them specifically in the provided text.
Were any new directors elected to the board?
Yes, the filing reports the election of directors.
What is the exact date of the reported event?
The earliest event reported is dated June 18, 2025.
What is Revolution Medicines' principal executive office address?
The principal executive offices are located at 700 Saginaw Drive, Redwood City, California 94063.
What is the SIC code for Revolution Medicines?
The Standard Industrial Classification (SIC) code is 2836 for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Revolution Medicines, Inc. (RVMDW).